1. Home Resources diabetes L. IDF Diabetes Atlas|Tenth Edition.https://diabetesatlas.org/. Accessed March 3 2022.
2. Lantus [prescribing information]. Sanofi‐Aventis U.S. LLC NJ USA. 2018. 021081s072lbl.pdf.https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021081s072lbl.pdf. Accessed March 3 2022.
3. US Food and Drug Administration. Information for Lantus (insulin glargine). Silver Spring MD USA: 2015.https://www.fda.gov/drugs/postmarket‐drug‐safety‐information‐patients‐and‐providers/information‐lantus‐insulin‐glargine. Accessed on March 3 2022.
4. INSULIN GLARGINE 300 U/mL (TOUJEO®);Scheen AJ;Rev Med Liege.,2016